Starling Oncology earnings

Next report

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 13, 2025 and Nov 13, 2024, after the close.

Last report: Aug 6, 2026, 16:32 ET (after the close). The filing on SEC EDGAR ↗

Across the last 1 report we hold closes for, the first close moved a median 28.46% either way. Up 1 of 1.

1. Aug 6, 202616:32 ET · after the close8-K ↗+28.46%1D
2. May 7, 202616:12 ET · after the close8-K ↗—1D
3. Mar 12, 202616:05 ET · after the close8-K ↗—1D
4. Jan 12, 202608:00 ET · before the open8-K ↗—1D
5. Nov 13, 202516:06 ET · after the close8-K ↗—1D
6. Aug 13, 202516:21 ET · after the close8-K ↗—1D
7. May 14, 202516:25 ET · after the close8-K ↗—1D
8. Mar 24, 202507:00 ET · before the open8-K ↗—1D
9. Nov 13, 202416:06 ET · after the close8-K ↗—1D
10. Aug 13, 202416:05 ET · after the close8-K ↗—1D
11. May 14, 202416:03 ET · after the close8-K ↗—1D
12. Apr 3, 202416:00 ET · after the close8-K ↗—1D
13. Mar 27, 202416:06 ET · after the close8-K ↗—1D
14. Nov 8, 202316:41 ET · after the close8-K ↗—1D
15. Aug 10, 202317:15 ET · after the close8-K ↗—1D
16. Aug 8, 202318:35 ET · after the close8-K ↗—1D

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Aug 4, 2026; a dash means we don't hold the closes for that report. Prior-session closes only; not a forecast, not advice.